Precigen, Inc. (PGEN) Provides Six-month Follow-up Data from Phase I Study of INXN-4001

Go back to Precigen, Inc. (PGEN) Provides Six-month Follow-up Data from Phase I Study of INXN-4001
(NASDAQ: PGEN) Delayed: 6.95 -0.15 (2.11%)
Previous Close $7.10    52 Week High
Open $6.89    52 Week Low
Day High $7.02    P/E N/A 
Day Low $6.72    EPS
Volume 1,203,123